Digicann Ventures Inc.

Equities

DCNN

CA25380E1060

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange Other stock markets 12:07:58 2024-05-21 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	-28.57%		+25.00%	+150.00%

Apr. 30	Digicann Ventures Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Digicann Ventures Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Agra Ventures Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021

May 02, 2022 at 07:37 pm EDT

Agra Ventures Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CAD 0.928208 million compared to CAD 1.49 million a year ago. Net loss was CAD 5.1 million compared to CAD 102.86 million a year ago.

Latest news about Digicann Ventures Inc.

Digicann Ventures Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Digicann Ventures Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
An unknown buyer acquired Agraflora Europe Gmbh from Digicann Ventures Inc..	23-10-22	CI
Digicann Ventures Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Agra Ventures Ltd. will Change its Name to Digicann Ventures Inc	23-08-08	CI
Digicann Ventures Inc. will Change its Ticker to DCNN from AGRA	23-08-08	CI
Agra Ventures "Amicably" Exits Unprofitable Joint Venture	23-06-19	MT
Agra Ventures Ltd. Mutually Agreed to Effectively Terminate and Amicably Exit the Propagation Services Canada Inc	23-06-16	CI
Agra Ventures Ltd. Appoints Jonathan Hirsh as an Independent Member of the Board of Directors	23-06-07	CI
Agra Ventures Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Agra Ventures Ltd. acquired Agraflora Europe Gmbh.	23-05-29	CI
Digicann Ventures Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI
Agra Ventures Ltd. Auditor Raises 'Going Concern' Doubt	23-04-30	CI
Agra Ventures Appoints Nick Kuzyk as Director, Effective March 1, 2023	23-02-23	CI
Agra Ventures Ltd. Appoints Nick Kuzyk as Permanent Chief Executive Officer, Effective March 1, 2023	23-02-23	CI
Digicann Ventures Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Agra Ventures' Boundary Bay Cannabis JV Receives over $910,000 in Purchase Orders in Last 3 Months	22-11-29	CI
Agra Ventures Brief: Adds David Grand has Resigned as CEO and Chairman Effective Immediately to Pursue a New Role Involving Boundary Bay Cannabis and Other Corporate Development Initiatives	22-09-07	MT
Agra Ventures Brief: Co Notes Kuzyk Has Direct Cannabis Industry Experience as Former Chief Strategy Officer and SVP Capital Markets of High Tide Inc.	22-09-07	MT
Agra Ventures Brief: Appointing Nick Kuzyk as Interim Chief Executive Officer	22-09-07	MT
Agra Ventures Ltd. Announces Executive Changes	22-09-07	CI
Agra Ventures Ltd. Announces Chief Executive Officer Changes	22-09-07	CI
Digicann Ventures Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
Agra Ventures Announces Resignation of Brian O’Neill as Director	22-07-15	CI
Agra Ventures Appoints David Grand as Director and Chair of Board of Directors	22-07-12	MT

Chart Digicann Ventures Inc.

Duration

Period

More charts

Company Profile

Digicann Ventures Inc., formerly Agra Ventures Ltd., is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.

Sector

Healthcare Facilities & Services

Calendar

2024-05-26 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
DIGICANN VENTURES INC.	+150.00%	556K
CRUCIAL INNOVATIONS CORP.	-.--%	339M
AYR WELLNESS INC.	+48.56%	299M
ASCEND WELLNESS HOLDINGS, INC.	+25.77%	279M
ORGANIGRAM HOLDINGS INC.	+51.16%	206M
INTERCURE LTD.	+161.28%	154M
JUSHI HOLDINGS INC.	+48.02%	132M
IANTHUS CAPITAL HOLDINGS, INC.	-42.86%	122M
THE CANNABIST COMPANY HOLDINGS INC.	-40.82%	119M
4FRONT VENTURES CORP.	+7.69%	118M

Medical Farming